Visualization of CombiHIVvac Vaccine Particles Using Electron Microscopy


Acandidate vaccine CombiHIVvac is developed; presently the clinical phase I trial has been completed successfully. CombiHIVvac combines the conserved polyepitope immunogens approaches in a novel self-adjuvanted microparticle concept. The artificial TBI (T cell and B cell immunogen) polypeptide used in the vaccine comprises epitopes from Env and Gag. The… (More)
DOI: 10.1089/aid.2016.0140

1 Figure or Table


  • Presentations referencing similar topics